DCCIK免疫治疗联合化疗治疗肺癌的临床效果  

Clinical effect of DCCIK immunotherapy combined with chemotherapy in the treatment of lung cancer

作　　者：王玲 邱志敏[2] 戴月 WANG Ling;QIU Zhi-min;DAI Yue(Department of Nursing,Jiangxi Health Vocational College,Jiangxi Province,Nanchang330052,China;Department of Comprehensive Oncology,Jiangxi Cancer Hospital,Jiangxi Province,Nanchang330029,China)

机构地区：[1]江西卫生职业学院护理系,江西南昌330052 [2]江西省肿瘤医院肿瘤综合内科,江西南昌330029

出　　处：《中国当代医药》2021年第20期106-108,共3页China Modern Medicine

基　　金：江西省教育厅科学技术研究项目(191413)。

摘　　要：目的探讨DCCIK免疫治疗联合化疗对肺癌患者的远近期临床治疗效果。方法回顾性分析2016年1—6月江西省肿瘤医院收治的60例肺癌患者的临床资料,按照治疗方法不同分为A组和B组,每组各30例。A组采用DCCIK免疫治疗联合化疗方式治疗,B组采用单纯化疗方案治疗。比较两组患者治疗后疾病控制率、卡氏(KPS)评分、远期疗效情况。结果治疗后,A组患者KPS总改善率高于B组,差异有统计学意义(P<0.05)。A组1年的生存率高于B组,A组2年的生存率高于B组患者,A组中位生存期高于B组,差异有统计学意义(P<0.05)。结论肺癌患者给予DCCIK免疫治疗联合化疗,可以显著改善患者的生活质量,提高疾病生存时间。Objective To investigate the long-term and short-term clinical effects of DCCIK immunotherapy combined with chemotherapy on patients with lung cancer.Methods The clinical data of 60 patients with lung cancer admitted to Jiangxi Cancer Hospital from January 2016 to June 2016 were retrospectively analyzed.According to different treatment methods,they were divided into group A and group B,with 30 patients in each group.Group A was treated with DCCIK combined with chemotherapy treatment methods,group B was treated with chemotherapy alone.The disease control rate,karnofsky(KPS)score,and long-term efficacy were compared between the two groups.Results After treatment,the total improvement rate of KPS in group A was higher than that in group B,and the difference was statistically significant(P<0.05).The 1-year survival rate of group A was higher than that of group B,the 2-year survival rate of group A was higher than that of group B,the median survival time of group A was higher than that of group B,and the differences were statistically significant(P<0.05).Conclusion DCCIK immunotherapy combined with chemotherapy is effective in the treatment of patients with lung cancer,which can significantly improve the quality of life of patients and increase the survival time of the disease.

关 键 词：细胞免疫治疗 化疗 肺癌 疗效 

分 类 号：R734.2[医药卫生—肿瘤]